losartan has been researched along with Di Guglielmo Disease in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De la Iglesia Iñigo, S | 1 |
| López-Jorge, CE | 1 |
| Gómez-Casares, MT | 1 |
| Lemes Castellano, A | 1 |
| Martín Cabrera, P | 1 |
| López Brito, J | 1 |
| Suárez Cabrera, A | 1 |
| Molero Labarta, T | 1 |
1 other study available for losartan and Di Guglielmo Disease
| Article | Year |
|---|---|
Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: a new role in the treatment of leukaemia for these agents.
Topics: Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Blotting, Northern; Blotting, Western; Captopri | 2009 |